Cassell PLC - Rule 8 Disclosure
October 12 1998 - 6:42AM
UK Regulatory
RNS No 2048m
CASSELL PLC
Date of Disclosure.12 OCTOBER 1998..
DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3
OF THE CITY CODE ON TAKE-OVERS AND MERGERS
Date of dealing..12 OCTOBER 1998....
Dealing in..CASSELL PLC....................................(name of company)
(1) Class of securities (eg ordinary shares)..20P ORDINARY SHARRES.......
(2) Amount bought Amount sold Price per unit
1,093,591 - 100P
(3) Resultant total of the same class owned or controlled
(and percentage of class).............1,093,591.................... (14.9%)
(4) Party making disclosure..SINGER & FRIENDLANDER LIMITED..................
(5) EITHER (a) Name of purchaser/vendor (Note 1).MACMILLAN PUBLISHES LIMITED
OR (b) if dealing for discretionary client(s), name of fund management
organisation
............................N/A................................................
(6) Reason for disclosure (Note 2)
(a) associate of (i) offeror (Note 3) NO
(ii) offeree company NO
Specify which category or categories of associate (1-8 overleaf)....N/A........
If category (8), explain.........N/A............................................
................................................................................
(b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more
of the class of relevant securities dealt in) NO
Signed, for and on behalf of the party named in (4) above......N/A..............
(Also print name of signatory)...GRAHAM HALL....................................
Telephone and extension number....0171 623 3000 EXT 5808........................
Note 1. Specify owner, not nominee or vehicle company. If relevant, also
identify controller of owner, eg where an owner normally acts on instructions of
a controller.
Note 2. Disclosure might be made for more than one reason; if so, state all
reasons.
Note 3. Specify which offeror if there is more than one.
Note 4. When an arrangement exists with any offeror, with the offeree company
or with an associate of any offeror or of the offeree company in relation to
relevant securities, details of such arrangement must be disclosed, as required
by Note 6 on Rule 8............................................................
...............................................................................
...............................................................................
For full details of disclosure requirements, see Rule 8 of the Code. If in
doubt, contact the Panel on Take-overs and Mergers, Tel. No: 0171-382 9026.
END
DCCGBGGPUBGRGUP
Cello Health (LSE:CLL)
Historical Stock Chart
From Oct 2024 to Nov 2024
Cello Health (LSE:CLL)
Historical Stock Chart
From Nov 2023 to Nov 2024